ARCHIVES

New Treatment Projects Get Go-Ahead; Groups Competition To Be Increased, VA Studies Face Cut

This article is from The Cancer Letter archive.

Vol. 03 No. 44 | November 4, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

Five Investigations Probe NIH Radiation Contamination

November 17, 1995

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

NTP Establishes Panel To Write New Guidelines For Detection, Evaluation Of Chemical Carcinogens

April 1, 1983